Sort
82,697 grants matching “vaccine development”
Surface-enhanced Raman Spectroscopy Immunoassay for Detection of Category A Patho
$918,238Marc D Porter · University Of Utah · R01 · FY2014 · AI
Virology Core Laboratory (VCL)
$918,144Thomas N Denny · Duke University · N01 · FY2025 · AI
CANCER AND LEUKEMIA GROUP B
$918,123Brigham And Women'S Hospital · U10 · FY2002 · CA
Assessment of Clinical Grade Near-Native Cleavage-Independent Trimer Protein Compared to Membrane-Bound mRNA Expression Coupled with Glycan Deletion, Restoration and Heterologous Boosting
$918,112Pyone Aye · Tulane University Of Louisiana · N01 · FY2021 · AI
Genes for Tolerance and Immunity Consortium
$918,064Australian National University · R01 · FY2002 · AI
Defining Drivers of HPV-associated Carcinogenesis
$918,000Paul F Lambert · University Of Wisconsin-Madison · R35 · FY2017 · CA
Transforming Clinical and Translational Research and Education at Rockefeller
$918,000Barry Coller · Rockefeller University · KL2 · FY2008 · RR
Defining Drivers of HPV-associated Carcinogenesis
$918,000Paul F Lambert · University Of Wisconsin-Madison · R35 · FY2018 · CA
Defining Drivers of HPV-associated Carcinogenesis
$918,000Paul F Lambert · University Of Wisconsin-Madison · R35 · FY2022 · CA
CI-TEAM Implementation for Biological Researchers, Educators, and Developers (CIBRED)
$918,000Stephen Cammer · Virginia Polytechnic Institute And State University · · FY2008 · CSE
Antigen recognition and activation of B-cell receptors of HIV-1 broadly neutralizing antibodies
$917,944S Munir Alam · Duke University · R01 · FY2019 · AI
India International Center for Excellence in Research
$917,866Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
WASHINGTON D.C. CONSORTIUM PEDIATRIC AIDS CLINICAL TRIAL
$917,826Children'S National Medical Center · U01 · FY2001 · AI
Optimizing Oral Pediatric HIV Vaccines to Prevent Breast Milk Transmission
$917,623Kristina Abel · Univ Of North Carolina Chapel Hill · R01 · FY2015 · DE
Basic Research Support for the CCR
$917,621Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Cervical, Anal & Oral HPV Persistence/Adolescent Girls
$917,545Angela Diaz · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · AI
Dissecting Polyclonal Sera to Reveal Correlates of Productive Immune Responses to HIV
$917,515Andrew Barrett Ward · Scripps Research Institute, The · R01 · FY2022 · AI
Mammalian and Plant-derived Antibody-based Therapies against Sudan Ebolavirus
$917,343John M Dye · Geneva Foundation · R01 · FY2017 · AI
Animal Models to Study Plague Infection and Immunity
$917,340B Joseph Hinnebusch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Immune Control and Immune Evasion during Acute Hepatitis C Virus Infection
$917,312Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2008 · AI
Non-viral gene therapy with eCD4-Ig
$917,294Brian D Quinlan · Emmune, Inc · R56 · FY2025 · AI
Defining Drivers of HPV-associated Carcinogenesis
$917,250Paul F Lambert · University Of Wisconsin-Madison · R35 · FY2020 · CA
Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever
$917,204Maja Sundberg · Thomas Jefferson University · N01 · FY2024 · AI
Therapeutics that target processivity complex proteins of pox and other viruses
$917,154Robert Paul Ricciardi · University Of Pennsylvania · U01 · FY2013 · AI
Influenza and Emerging Infectious Diseases
$917,122Richard Davey · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI